4.5 Article

rTMS combined with CBT as a next step in antidepressant non-responders: a study protocol for a randomized comparison with current antidepressant treatment approaches

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials

Luca Sforzini et al.

Summary: The document discusses the criteria for treatment-resistant depression (TRD) and partially responsive depression (PRD) as subtypes of major depressive disorder (MDD) which are not clearly defined, using a Delphi-method-based consensus approach. It reviews literature and gathers international experts to evaluate controversies and provide recommendations on designing clinical trials and guiding research. It aims to support the design of a protocol for platform trials of new medications for TRD/PRD as part of the EUropean Patient-cEntric clinicAl tRial pLatforms, Innovative Medicines Initiative (EU-PEARL, IMI) MDD project.

MOLECULAR PSYCHIATRY (2022)

Article Economics

The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018)

Paul E. Greenberg et al.

Summary: The number of US adults with major depressive disorder (MDD) increased by 12.9% between 2010 and 2018, resulting in a 37.9% increase in the economic burden. The largest growth in costs was observed in workplace costs. Despite the overall increase in the number of MDD patients, the direct cost per individual decreased, and the proportion of treated patients remained stable, indicating unmet treatment needs. Further research into MDD treatment services is warranted.

PHARMACOECONOMICS (2021)

Article Psychiatry

Cost-Utility Analysis of Electroconvulsive Therapy and Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Ontario

Kyle P. Fitzgibbon et al.

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2020)

Review Clinical Neurology

The identification, assessment and management of difficult-to-treat depression: An international consensus statement

R. H. McAllister-Williams et al.

JOURNAL OF AFFECTIVE DISORDERS (2020)

Meeting Abstract Clinical Neurology

Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls

K. Koehler-Forsberg et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)

Article Economics

Dutch Tariff for the Five-Level Version of EQ-5D

Matthijs M. Versteegh et al.

VALUE IN HEALTH (2016)

Article Medicine, General & Internal

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

Don Husereau et al.

BMC MEDICINE (2013)

Article Psychology, Clinical

A randomized, prospective pilot study of patient expectancy and antidepressant outcome

B. R. Rutherford et al.

PSYCHOLOGICAL MEDICINE (2013)

Article Clinical Neurology

The economic cost of brain disorders in Europe

J. Olesen et al.

EUROPEAN JOURNAL OF NEUROLOGY (2012)

Article Psychiatry

Where in the Brain Is Depression?

Mayur Pandya et al.

CURRENT PSYCHIATRY REPORTS (2012)

Article Medicine, General & Internal

Consort 2010 statement: extension to cluster randomised trials

Marion K. Campbell et al.

BMJ-BRITISH MEDICAL JOURNAL (2012)

Article Medicine, General & Internal

CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials

Kenneth F. Schulz et al.

BMC MEDICINE (2010)

Article Psychology, Clinical

Adding Psychotherapy to Pharmacotherapy in the Treatment of Depressive Disorders in Adults: A Meta-Analysis

Pim Cuijpers et al.

JOURNAL OF CLINICAL PSYCHIATRY (2009)

Article Psychiatry

Population-based study of first onset and chronicity in major depressive disorder

William W. Eaton et al.

ARCHIVES OF GENERAL PSYCHIATRY (2008)

Article Clinical Neurology

Excess mortality in depression: a meta-analysis of community studies

P Cuijpers et al.

JOURNAL OF AFFECTIVE DISORDERS (2002)